News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
20,962 Results
Type
Article (676)
Company Profile (4)
Press Release (20282)
Multimedia
Podcasts (2)
Webinars (1)
Section
Business (10016)
Career Advice (15)
Deals (1479)
Drug Delivery (1)
Drug Development (1741)
Employer Resources (1)
FDA (218)
Job Trends (486)
News (11954)
Policy (469)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Standard (1)
Academia (34)
Accelerated approval (3)
ADA (5)
Allergies (4)
Alliances (404)
ALS (11)
Alzheimer's disease (26)
Antibody-drug conjugate (ADC) (26)
Approvals (249)
Artificial intelligence (9)
ASCO (8)
Autoimmune disease (13)
Automation (1)
Bankruptcy (3)
Belgium (1)
Best Places to Work (445)
Biologics (1)
Biosimilars (6)
BioSpace Insights (1)
Biotechnology (3)
Bispecific (1)
Bladder cancer (4)
Breast cancer (13)
Cancer (165)
Cardiovascular disease (22)
Career advice (14)
Career pathing (1)
CAR-T (5)
CDMO (2)
Cell therapy (12)
Cervical cancer (1)
Clinical research (1753)
Collaboration (36)
Commercialization (3)
Compensation (14)
Complete response letters (1)
COVID-19 (47)
CRISPR (2)
C-suite (9)
Cystic fibrosis (17)
Data (311)
Depression (7)
Dermatology (3)
Diabetes (28)
Diagnostics (196)
Digital health (5)
Drug discovery (5)
Drug pricing (1)
Duchenne muscular dystrophy (10)
Earnings (10205)
Employer resources (1)
Events (1146)
Executive appointments (4)
FDA (424)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (35)
Gene editing (9)
Gene therapy (12)
GLP-1 (37)
Government (59)
Guidances (122)
Healthcare (582)
Hematology (4)
HIV (2)
IgA nephropathy (12)
Immunology and inflammation (9)
Immuno-oncology (2)
Indications (8)
Infectious disease (64)
Inflammatory bowel disease (5)
Influenza (3)
Intellectual property (5)
Interviews (1)
IPO (1135)
Job creations (61)
Job search strategy (13)
JPM (1)
Kidney disease (2)
Labor market (4)
Layoffs (12)
Legal (64)
Liver cancer (3)
Lung cancer (34)
Lymphoma (25)
Machine learning (2)
Management (1)
Manufacturing (17)
MASH (5)
Medical affairs (1)
Medical device (500)
Medtech (515)
Mergers & acquisitions (374)
Metabolic disorders (58)
mRNA (3)
Multiple sclerosis (6)
Neurodegenerative disease (16)
Neuropsychiatric disorders (4)
Neuroscience (88)
NextGen: Class of 2026 (125)
Non-profit (64)
Now hiring (2)
Obesity (28)
Opinion (4)
Ovarian cancer (5)
Pain (5)
Pancreatic cancer (6)
Parkinson's disease (6)
Patents (8)
Patient recruitment (15)
Patient selection (1)
Peanut (1)
People (308)
Pharmaceutical (1)
Pharmacy benefit managers (3)
Phase 1 (434)
Phase 2 (666)
Phase 3 (806)
Pipeline (983)
Policy (1)
Postmarket research (40)
Preclinical (86)
Press Release (1)
Prostate cancer (16)
Psychedelics (2)
Radiopharmaceuticals (6)
Rare diseases (52)
Real estate (54)
Regulatory (469)
Reports (3)
Research institute (29)
Resumes & cover letters (1)
RSV (12)
Schizophrenia (8)
Series A (7)
Series B (6)
Sickle cell disease (9)
Spinal muscular atrophy (11)
Startups (48)
Supply chain (1)
Tariffs (2)
The Weekly (2)
Vaccines (15)
Venture capital (6)
Weight loss (16)
Women's health (5)
Date
Last 7 days (10)
Last 30 days (55)
Last 365 days (1274)
2026 (989)
2025 (1151)
2024 (1353)
2023 (1483)
2022 (2478)
2021 (2880)
2020 (2429)
2019 (1161)
2018 (858)
2017 (766)
2016 (497)
2015 (798)
2014 (537)
2013 (257)
2012 (313)
2011 (435)
2010 (401)
Location
Africa (10)
Alabama (4)
Arizona (3)
Asia (1190)
Australia (128)
California (686)
Canada (112)
China (63)
Colorado (31)
Connecticut (17)
Delaware (24)
Europe (2344)
Florida (104)
Georgia (30)
Idaho (1)
Illinois (49)
Indiana (36)
Japan (13)
Kansas (2)
Kentucky (3)
Louisiana (7)
Maine (5)
Maryland (90)
Massachusetts (392)
Michigan (23)
Minnesota (40)
Missouri (5)
Montana (2)
Nevada (3)
New Hampshire (3)
New Jersey (223)
New York (162)
North Carolina (62)
Northern California (354)
Ohio (16)
Pennsylvania (115)
South America (16)
Southern California (295)
Tennessee (6)
Texas (92)
United States (2235)
Utah (21)
Virginia (6)
Washington D.C. (3)
Washington State (41)
Wisconsin (6)
20,962 Results for "105".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kairos Pharma Reports Positive, Statistically Significant Interim Efficacy Data from Phase 2 Trial of ENV-105 in Metastatic Prostate Cancer
October 6, 2026
·
3 min read
Press Releases
Kye Pharmaceuticals places No. 105 on The Globe and Mail’s eighth annual ranking of Canada’s Top Growing Companies.
September 27, 2026
·
3 min read
Press Releases
Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet
August 4, 2026
·
6 min read
Press Releases
Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties
July 14, 2026
·
5 min read
China
Pfizer bets up to $10.5B in 12-candidate cancer collab with China’s Innovent
Pfizer continues its dealmaking spree by striking a back-heavy partnership with China’s Innovent Biologics to assemble a pipeline of antibody-based therapies for cancer.
May 29, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Kairos Pharma Reports Breakthrough Interim Safety Data in Phase 1 Trial of ENV-105 in EGFR-Mutated Lung Cancer Patients — Targeting a $10 Billion Drug Resistance Market
July 16, 2026
·
6 min read
Press Releases
Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering
February 8, 2026
·
3 min read
Press Releases
Cognito Therapeutics Announces Oversubscribed $105 Million Series C Financing to Advance Spectris™ in Alzheimer’s Disease
March 5, 2026
·
3 min read
Press Releases
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
March 23, 2026
·
5 min read
Press Releases
Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA
January 5, 2026
·
3 min read
1 of 2,097
Next
